SCM
AXSM icon

Sterling Capital Management’s Axsome Therapeutics AXSM Stock Holding History

Sterling Capital Management’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$69.8K Buy
285
+16
+6% +$3.47K ﹤0.01% 1496
2026
Q1 		$45.5K Buy
269
+1
+0.4% +$173 ﹤0.01% 1678
2025
Q4 		$48.9K Buy
268
+170
+173% +$23.7K ﹤0.01% 1812
2025
Q3 		$11.9K Hold
98
– – ﹤0.01% 2393
2025
Q2 		$10.2K Buy
98
+60
+158% +$6.35K ﹤0.01% 2121
2025
Q1 		$4.43K Buy
38
+1
+3% +$114 ﹤0.01% 2231
2024
Q4 		$3.13K Hold
37
– – ﹤0.01% 2637
2024
Q3 		$3.33K Buy
+37
New +$3.23K ﹤0.01% 1940

Other funds holding AXSM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Sterling Capital Management's AXSM Position: Q2 2026 in Review

Sterling Capital Management increased its Axsome Therapeutics (AXSM) stake by 5.9% in Q2 2026, buying an estimated $3.47K and bringing the position to 285 shares worth $69.8K. The position accounts for ﹤0.01% of the portfolio, ranked #1496.

Sterling Capital Management first reported a position in AXSM in Q3 2024 and has held it in 8 quarters since. 506 funds tracked by Wall St. Rank hold AXSM as of Q2 2026.

  • Sterling Capital Management held 285 shares of Axsome Therapeutics worth $69.8K as of Q2 2026.
  • Sterling Capital Management bought 16 Axsome Therapeutics shares in Q2 2026, an estimated $3.47K.
  • Axsome Therapeutics made up ﹤0.01% of Sterling Capital Management's portfolio in Q2 2026, its #1496 holding.
  • Sterling Capital Management first reported a position in Axsome Therapeutics in Q3 2024 and has held it in 8 quarters since.
  • 506 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q2 2026.

Based on Sterling Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.